Earnings Call Summary | Moolec Science(MLEC.US) Q3 2024 Earnings Conference
Earnings Call Summary | Moolec Science(MLEC.US) Q3 2024 Earnings Conference
The following is a summary of the Moolec Science SA (MLEC) Q3 2024 Earnings Call Transcript:
以下是Moolec Science SA (MLEC) 2024第三季度业绩会记录摘要：
Financial Performance:
金融业绩：
Revenue increased year-over-year from nil to approximately $1.3 million.
Gross margin stood at 18%.
Operational cash flow was approximately $2.7 million with a decrease in cash utilization year-over-year.
Moolec's cash position strengthened by approximately $2 million due to additional funding.
营业收入同比增长，从零增至约130万美元。
毛利率为18%。
运营现金流约为270万美元，年同比现金利用减少。
由于额外融资，Moolec现金状况增强了约200万美元。
Business Progress:
业务进展：
Achieved USDA-APHIS regulatory approval for Piggy Sooy.
Initiated field trials for Piggy Sooy in three different U.S. locations.
GLASO is in pre-commercial stages with intended market penetration in 2025.
Two U.S. patents granted for SPC2 technology extending protection till 2041.
Piggy Sooy已获USDA-APHIS监管批准。
在美国三个不同地点启动了Piggy Sooy的田间试验。
GLASO处于商业前期阶段，计划于2025年进入市场。
SPC2技术获得两项美国专利，保护期延长至2041年。
Opportunities:
机会：
Moolec's Piggy Sooy provides a sustainable alternative to traditional livestock farming, reducing water and CO2 emissions.
Expected commercial adoption and scaling of Piggy Sooy and GLASO in the forthcoming years.
Moolec的Piggy Sooy提供了可持续的传统畜牧业替代方案，减少了水和二氧化碳排放。
预计在未来几年内，Piggy Sooy和GLASO的商业采用和规模化将会实现。
Risks:
风险：
Dependence on the success and commercial acceptance of Piggy Sooy and other products still in pre-commercial or early commercial stages.
依赖于Piggy Sooy和其他仍处于商业前期或早期商业阶段的产品的成功和商业接受程度。
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：本文由AI生成。文章内容的准确性无法完全保证。有关更全面的详细信息，请参阅IR网站。本文只是为投资者提供参考，没有任何指导或推荐建议。